Mesoblast, a leader in allogeneic cellular medicines for inflammatory diseases, has Dr. George as its largest shareholder, according to a Feb. 23 press release.
Dr. George has a background in medical science with experience in operations, having built an ASC startup into a billion-dollar organization, according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.